Safety and Immunogenicity of CJ-40010 in Healthy Subjects

NCT04182932 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Hand, Foot and Mouth Disease

Interventions

BIOLOGICAL: CJ-40010 EV71 vaccine A dose
BIOLOGICAL: CJ-40010 EV71 vaccine B dose
BIOLOGICAL: CJ-40010 CVA16 vaccine C dose
BIOLOGICAL: CJ-40010 CVA16 vaccine D dose
BIOLOGICAL: CJ-40010 Bivalent vaccine E dose
BIOLOGICAL: CJ-40010 Bivalent vaccine high dose
BIOLOGICAL: Placebo

Sponsor

HK inno.N Corporation